UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications

Leukemia, 2014-01, Vol.28 (1), p.155-165

2014

Volltextzugriff (PDF)

Continuous Glucose Monitoring Use in Older Adults for Optimal Diabetes Management

Diabetes technology & therapeutics, 2023-06, Vol.25 (S3), p.S-56-S-64

Munshi, Medha N.

2023

Volltextzugriff (PDF)

Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial

The lancet oncology, 2022-01, Vol.23 (1), p.91-103

2022

Volltextzugriff (PDF)

Targeting PD1-PDL1 immune checkpoint in plasmacytoid dendritic cell interactions with T cells, natural killer cells and multiple myeloma cells

Leukemia, 2015-06, Vol.29 (6), p.1441-1444

2015

Volltextzugriff (PDF)

Comparison of post-transplantation diabetes mellitus incidence and risk factors between kidney and liver transplantation patients

PloS one, 2020-01, Vol.15 (1), p.e0226873-e0226873

2020

Volltextzugriff (PDF)

Cognitive Dysfunction in Older Adults With Diabetes: What a Clinician Needs to Know

Diabetes care, 2017-04, Vol.40 (4), p.461-467

Munshi, Medha N

2017

Volltextzugriff (PDF)

Continuous Glucose Monitoring in Adults with Diabetes in Clinical Practice: Increased Access and Education Needed

Journal of general internal medicine : JGIM, 2023-06, Vol.38 (8), p.2011-2014

2023

Volltextzugriff (PDF)

SAR650984 directly induces multiple myeloma cell death via lysosomal-associated and apoptotic pathways, which is further enhanced by pomalidomide

Leukemia, 2016-02, Vol.30 (2), p.399-408

2016

Volltextzugriff (PDF)

Histone deacetylase 3 as a novel therapeutic target in multiple myeloma

Leukemia, 2014-03, Vol.28 (3), p.680-689

2014

Volltextzugriff (PDF)

Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts

The New England journal of medicine, 2011-10, Vol.365 (15), p.1384-1395

2011

Volltextzugriff (PDF)

Protein arginine methyltransferase 5 has prognostic relevance and is a druggable target in multiple myeloma

Leukemia, 2018-04, Vol.32 (4), p.996-1002

2018

Volltextzugriff (PDF)

Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo

Leukemia, 2015-11, Vol.29 (11), p.2173-2183

2015

Volltextzugriff (PDF)

Adoption of sodium-glucose cotransporter-2 inhibitors among prescribers caring for nursing home residents

Journal of the American Geriatrics Society (JAGS), 2023-08, Vol.71 (8), p.2585-2592

2023

Volltextzugriff (PDF)

Nucleotide excision repair is a potential therapeutic target in multiple myeloma

Leukemia, 2018-01, Vol.32 (1), p.111-119

2018

Volltextzugriff (PDF)

Microbial fuel cell performance for aromatic hydrocarbon bioremediation and common effluent treatment plant wastewater treatment with bioelectricity generation through series‐parallel connection

Letters in applied microbiology, 2022-10, Vol.75 (4), p.785-795

2022

Volltextzugriff (PDF)

Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines

Leukemia, 2018-04, Vol.32 (4), p.1044-1047

2018

Volltextzugriff (PDF)

IMWG consensus on risk stratification in multiple myeloma

Leukemia, 2014-02, Vol.28 (2), p.269-277

2014

Volltextzugriff (PDF)

Diabetes Management in the Elderly

Diabetes spectrum, 2018-08, Vol.31 (3), p.245-253

2018

Volltextzugriff (PDF)

Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma

Leukemia, 2008-10, Vol.22 (10), p.1925-1932

2008

Volltextzugriff (PDF)

Comparative safety of sulfonylureas among U.S. nursing home residents

Journal of the American Geriatrics Society (JAGS), 2023-04, Vol.71 (4), p.1047-1057

2023

Volltextzugriff (PDF)

The use of novel agents in the treatment of relapsed and refractory multiple myeloma

Leukemia, 2009-12, Vol.23 (12), p.2222-2232

2009

Volltextzugriff (PDF)

AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3β activation and RNA polymerase II inhibition

Oncogene, 2010-04, Vol.29 (16), p.2325-2336

2010

Volltextzugriff (PDF)

Blockade of deubiquitylating enzyme Rpn11 triggers apoptosis in multiple myeloma cells and overcomes bortezomib resistance

Oncogene, 2017-10, Vol.36 (40), p.5631-5638

2017

Volltextzugriff (PDF)

HDAC inhibition by LBH589 affects the phenotype and function of human myeloid dendritic cells

Leukemia, 2011-01, Vol.25 (1), p.161-168

2011

Volltextzugriff (PDF)

1 – 25 von 1.282

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.114)
Mit Volltextzugriff
(1.074)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(83)
Leukemia
(49)
Journal Of Clinical Oncology
(34)
Cancer Research
(26)
British Journal Of Haematology
(24)
Oncogene
(22)
Astronomy And Astrophysics
(21)
Transplantation And Cellular Therapy
(20)
Clinical Lymphoma & Myeloma
(17)
Diabetes Care
(16)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implications

Continuous Glucose Monitoring Use in Older Adults for Optimal Diabetes Management

Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial

Targeting PD1-PDL1 immune checkpoint in plasmacytoid dendritic cell interactions with T cells, natural killer cells and multiple myeloma cells

Comparison of post-transplantation diabetes mellitus incidence and risk factors between kidney and liver transplantation patients

Cognitive Dysfunction in Older Adults With Diabetes: What a Clinician Needs to Know

Continuous Glucose Monitoring in Adults with Diabetes in Clinical Practice: Increased Access and Education Needed

SAR650984 directly induces multiple myeloma cell death via lysosomal-associated and apoptotic pathways, which is further enhanced by pomalidomide

Histone deacetylase 3 as a novel therapeutic target in multiple myeloma

Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts

Protein arginine methyltransferase 5 has prognostic relevance and is a druggable target in multiple myeloma

Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo

Adoption of sodium-glucose cotransporter-2 inhibitors among prescribers caring for nursing home residents

Nucleotide excision repair is a potential therapeutic target in multiple myeloma

Microbial fuel cell performance for aromatic hydrocarbon bioremediation and common effluent treatment plant wastewater treatment with bioelectricity generation through series‐parallel connection

Biological and prognostic impact of APOBEC-induced mutations in the spectrum of plasma cell dyscrasias and multiple myeloma cell lines

IMWG consensus on risk stratification in multiple myeloma

Diabetes Management in the Elderly

Lenalidomide inhibits osteoclastogenesis, survival factors and bone-remodeling markers in multiple myeloma

Comparative safety of sulfonylureas among U.S. nursing home residents

The use of novel agents in the treatment of relapsed and refractory multiple myeloma

AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3β activation and RNA polymerase II inhibition

Blockade of deubiquitylating enzyme Rpn11 triggers apoptosis in multiple myeloma cells and overcomes bortezomib resistance

International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)

HDAC inhibition by LBH589 affects the phenotype and function of human myeloid dendritic cells

Suchergebnisse filtern